GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » China SXT Pharmaceuticals Inc (NAS:SXTC) » Definitions » Receivables Turnover

China SXT Pharmaceuticals (China SXT Pharmaceuticals) Receivables Turnover : 0.71 (As of Sep. 2023)


View and export this data going back to 2019. Start your Free Trial

What is China SXT Pharmaceuticals Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. China SXT Pharmaceuticals's Revenue for the six months ended in Sep. 2023 was $0.94 Mil. China SXT Pharmaceuticals's average Accounts Receivable for the six months ended in Sep. 2023 was $1.33 Mil. Hence, China SXT Pharmaceuticals's Receivables Turnover for the six months ended in Sep. 2023 was 0.71.


China SXT Pharmaceuticals Receivables Turnover Historical Data

The historical data trend for China SXT Pharmaceuticals's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

China SXT Pharmaceuticals Receivables Turnover Chart

China SXT Pharmaceuticals Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Receivables Turnover
Get a 7-Day Free Trial 2.07 1.29 1.15 0.66 0.84

China SXT Pharmaceuticals Semi-Annual Data
Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Receivables Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.25 0.44 0.36 0.33 0.71

Competitive Comparison of China SXT Pharmaceuticals's Receivables Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, China SXT Pharmaceuticals's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


China SXT Pharmaceuticals's Receivables Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, China SXT Pharmaceuticals's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where China SXT Pharmaceuticals's Receivables Turnover falls into.



China SXT Pharmaceuticals Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

China SXT Pharmaceuticals's Receivables Turnover for the fiscal year that ended in Mar. 2023 is calculated as

Receivables Turnover (A: Mar. 2023 )
=Revenue / Average Total Inventories
=Revenue (A: Mar. 2023 ) / ((Accounts Receivable (A: Mar. 2022 ) + Accounts Receivable (A: Mar. 2023 )) / count )
=1.972 / ((3.333 + 1.345) / 2 )
=1.972 / 2.339
=0.84

China SXT Pharmaceuticals's Receivables Turnover for the quarter that ended in Sep. 2023 is calculated as

Receivables Turnover (Q: Sep. 2023 )
=Revenue / Average Total Inventories
=Revenue (Q: Sep. 2023 ) / ((Accounts Receivable (Q: Mar. 2023 ) + Accounts Receivable (Q: Sep. 2023 )) / count )
=0.94 / ((1.345 + 1.311) / 2 )
=0.94 / 1.328
=0.71

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


China SXT Pharmaceuticals  (NAS:SXTC) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.


China SXT Pharmaceuticals Receivables Turnover Related Terms

Thank you for viewing the detailed overview of China SXT Pharmaceuticals's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


China SXT Pharmaceuticals (China SXT Pharmaceuticals) Business Description

Traded in Other Exchanges
Address
No. 178 Taidong Road North, Jiangsu, Taizhou, CHN, 225300
China SXT Pharmaceuticals Inc is a pharmaceutical company that is focused on the research, development, manufacture, marketing, and sales of Traditional Chinese Medicine Pieces (TCMP), particularly, Advanced TCMP (Directed-oral TCMP, and After-soaking TCMP) which is a sort of Traditional Chinese Medicine (TCM) that has been processed to be ready for use without decoction. Geographically, the firm generates a majority of its revenue from the People's Republic of China.

China SXT Pharmaceuticals (China SXT Pharmaceuticals) Headlines

From GuruFocus

China SXT Pharmaceuticals, Inc. Announces 1 for 20 Reverse Share Split

By GuruFocusNews GuruFocusNews 06-07-2022